- Home
- KZIA vs LDWY Comparison
KZIA vs LDWY Comparison
Compare KZIA & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- LDWY
- Stock Information
- Founded
- KZIA 1994
- LDWY 1990
- Country
- KZIA Australia
- LDWY United States
- Employees
- KZIA N/A
- LDWY N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- LDWY Advertising
- Sector
- KZIA Health Care
- LDWY Consumer Discretionary
- Exchange
- KZIA Nasdaq
- LDWY Nasdaq
- Market Cap
- KZIA 6.0M
- LDWY 6.9M
- IPO Year
- KZIA 1999
- LDWY 1991
- Fundamental
- Price
- KZIA $0.88
- LDWY $4.12
- Analyst Decision
- KZIA Strong Buy
- LDWY
- Analyst Count
- KZIA 2
- LDWY 0
- Target Price
- KZIA $11.50
- LDWY N/A
- AVG Volume (30 Days)
- KZIA 5.5M
- LDWY 5.3K
- Earning Date
- KZIA 03-26-2025
- LDWY 03-31-2025
- Dividend Yield
- KZIA N/A
- LDWY N/A
- EPS Growth
- KZIA N/A
- LDWY N/A
- EPS
- KZIA N/A
- LDWY N/A
- Revenue
- KZIA $1,655,324.00
- LDWY $31,581,000.00
- Revenue This Year
- KZIA N/A
- LDWY N/A
- Revenue Next Year
- KZIA N/A
- LDWY N/A
- P/E Ratio
- KZIA N/A
- LDWY N/A
- Revenue Growth
- KZIA 248000.00
- LDWY N/A
- 52 Week Low
- KZIA $0.85
- LDWY $3.02
- 52 Week High
- KZIA $15.80
- LDWY $6.88
- Technical
- Relative Strength Index (RSI)
- KZIA 29.00
- LDWY 45.61
- Support Level
- KZIA $0.90
- LDWY $3.85
- Resistance Level
- KZIA $1.60
- LDWY $4.75
- Average True Range (ATR)
- KZIA 0.14
- LDWY 0.17
- MACD
- KZIA 0.02
- LDWY -0.01
- Stochastic Oscillator
- KZIA 4.00
- LDWY 30.00
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.